| Literature DB >> 33550764 |
Uygar Miçooğulları1, Davut Kamacı2, Mehmet Yıldızhan2, Furkan Umut Kılıç3, Taha Çetin1, Özer Ural Çakıcı4, Murat Keske5, Mehmet Yiğit Yalçın1, Arslan Ardıçoğlu3.
Abstract
Background/aim: In this study, we aimed to compare the results of prone and Barts “flank-free” modified supine percutaneous nephrolithotomy (PCNL) operations in our clinic. Materials and methods: The data from patients that underwent Barts “flank-free” modified supine PCNL (BS-PCNL) (n = 52) between June 2018 and July 2020 and prone PCNL (P-PCNL) (n = 286) between April 2014 and June 2018 were retrospectively evaluated. Of those 286 patients, 104 patients whose sex, age, body mass index, American Society of Anesthesiology score, stone localization, stone size, and hydronephrosis matched the BS-PCNL group in a 1:2 ratio were included in the study. The groups were compared in terms of intraoperative outcome, complication rates, and stone-free rates.Entities:
Keywords: Barts flank-free modified supine position; kidney stone; prone; Percutaneous nephrolithotomy; Barts “flank-free” modified supine position; stone-free rate
Mesh:
Year: 2021 PMID: 33550764 PMCID: PMC8283509 DOI: 10.3906/sag-2011-21
Source DB: PubMed Journal: Turk J Med Sci ISSN: 1300-0144 Impact factor: 0.973
Demographic data and stone characteristics.
| BS-PCNL (n = 52) | P-PCNL (n = 104) | p | |
|---|---|---|---|
| Sex (female/male) | 20/32 | 38/66 | 0.81a |
| BMI | 24.4 ± 2.9 | 24.8 ± 2.9 | 0.35b |
| Age | 43.9 ± 16.2 | 40.8 ± 14.6 | 0.24b |
| ASA score123 | 36 (69.2%)14 (26.9%)2 (3.8%) | 66 (63.5%)34 (32.7%)4 (3.8%) | 0.75a |
| Previous ESWL/surgeryESWLURSPCNLOpen surgery | 2 (3.8%)3 (5.8%)4 (7.7%)0 | 3 (2.9%)4 (3.8%)9 (8.7%)0 | 0.93a |
| Stone opacity (opaque/nonopaque). | 48/4 | 93/11 | 0.56a |
| Stone density (HU), median (min-maks) | 1180 (690–2080) | 1130 (610–1980) | 0.5c |
| Stone localization Lower calyxMiddle calyxUpper calyxPelvisMultiple calycesStaghorn-shaped | 19 (36.5%)4 (7.7%)2 (3.8%)25 (48.1)1 (1.9%)1 (1.9%) | 47 (45.2%)6 (5.8%)2 (1.9%)44 (42.3%)2 (1.9%)3 (2.9%) | 0.88a |
| Stone size (mm) | 32.1 ± 7.3 | 32.7 ± 8.2 | 0.38b |
| Hydronephrosis (no/mild/severe) | 24/24/4 | 46/51/7 | 0.93a |
Operative data.
| BS-PCNL (n = 52) | P-PCNL (n = 104) | p | |
|---|---|---|---|
| Operation side (right/left) | 21/31 | 46/58 | 0.64a |
| Operation time (min) | 80.2 ± 15.1 | 92.4 ± 22.7 | 0.001a |
| Fluoroscopy time (min) | 3.53 ± 1.4 | 3.4 ± 1.2 | 0.31b |
| Double-J stent placement | 3 (5.8%) | 8 (7.7%) | 0.75a |
| Nephrostomy placement | 49 (94.2%) | 96 (92.3%) | 0.75a |
| Access poleLowerMiddleUpperMultiple | 45 (86.5%)3 (5.8%)2 (3.8)2 (3.8%) | 92 (88.5%)88 (7.7%)2 (1.9%)2 (1.9%) | 0.75a |
| Entry localizationAbove 11th ribAbove 12th ribSubcostal | 1 (1.9%)2 (3.8%)49 (94.2%) | 3 (2.9%)5 (4.8%)96 (92.3%) | 0.9a |
| Intraoperative complication Satava grade 1Satava grade 2 | 12 (23.1%)3 (5.8%) | 16 (15.4%)7 (6.7%) | 0.49a |
Post-operative data.
| BS-PCNL (n = 52) | P-PCNL (n = 104) | p | |
|---|---|---|---|
| Clavien–Dindo classificationGrade 1FeverSerum creatinine elevation Grade 2Blood transfusionUrinary tract infectionGrade 3aDouble-J stent placement for urine leakageAngioembolization | 5 (9.6%)413 (5.8%)211 (1.9%)10 | 12 (11.5%)847 (6.7%)522 (1.9%)11 | 0.83a |
| Hematocrit drop (gr/dL) | 3.2 ± 2.8 | 2.9 ± 2.6 | 0.31b |
| Hospital length of stay (day) | 1.44 ± 0.77 | 1.36 ± 0.68 | 0.52b |
| Nephrostomy duration(day) | 1.26 ± 0.56 | 1.25 ± 0.69 | 0.88b |
| Stone-free after the first access | 43 (82.7%) | 77 (74%) | 0.31a |
| Stone-free after PCNL alone | 46 (88.5%) | 98 (94.2%) | 0.21a |
| Overall stone-free rates | 48 (92.3%) | 98 (94.2%) | 0.72a |